Cellebrite DI Ltd. announced that Haim Shani has retired as a director of the Company, effective immediately. Mr. Shani had been a distinguished member of the Board since 2019, including two years as Chairman from August 2021 until August 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.26 USD | +1.90% | +0.22% | +29.62% |
04-19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
04-01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.62% | 2.27B | |
+9.92% | 3,082B | |
+7.87% | 84.92B | |
+5.22% | 78.23B | |
-13.71% | 54.06B | |
-23.95% | 46.79B | |
+21.61% | 45.87B | |
+22.94% | 42.68B | |
+57.44% | 37.28B | |
-9.34% | 24.89B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Cellebrite Di Ltd Announces Retainment of Haim Shani as Director